期刊文献+

胰腺癌合并糖尿病24例临床分析 被引量:3

The clinical study on 24 cases of diabetes mellitus complicated by pancreatic carcinoma
下载PDF
导出
摘要 目的 总结胰腺癌合并糖尿病的临床特点 ,以提高早期胰腺癌的诊断率。方法 回顾性分析我院 10年来胰腺癌合并糖尿病患者的临床特点 ,分析其一般情况、合并症、糖尿病家族史、肿瘤指标、糖耐量和诊治过程 ,并与单纯 2型糖尿病患者比较。结果 胰腺癌合并糖尿病血糖水平和胰岛素水平与 2型糖尿病相似 ,有高胰岛素血症 ,但又有独特的临床特点 :①发病年龄相对较大 ,常大于 6 0岁 ,女性多见 ;②基本无DM家族史 ;③无三多症状 ,但短期内体重下降较明显 ;④起病时常有腹痛或腹部不适感 ;⑤合并高血压和冠心病 ,尤其是高脂血症相对少见 ;⑥肿瘤指标CA19 9和CEA常有异常。胰腺癌所致的糖尿病常在胰腺癌早期即可出现。结论 胰腺癌所致糖尿病有一定的发病特点 ,借助此特点 ,有望提高早期胰腺癌的诊断率。 Objective To study the clinical characteristics of diabetes mellitus complicated by pancreatio carcinoma(DMPC) and to improve the diagnosis of the early pancreatic carcinoma.Methods To analysis retrospectively all patients suffered from diabetes mellitus complicated by pancreatic carcinoma,including general presentation,accompanying diseases,diabetes family history,tumor marker and glucose intolerance.Results The patients of DMPC had hyperinsulinemia similar to those of diabetes mellitus type,but also had distinct characteristics as follows:①The onset of mean age was often more than 60 years.And the ratio of femal to male was 2∶1.②There was almost no family history of diabetes.③The typical symptoms such as polyphagia,polyposia and polyuria was rare,but weight loss(more than 5 kg in three moths) was significant.④Abdominal pain was common in the onset.⑤The accompanying diseases including hypertension,conorary heart disease and hyperlipidemia were less common.⑥The tumor marker CA19 9 and CEA were often abnormal.Diabetes was often presented at the early stage of pancreatic carcinoma,but most of them were misdiagnosed as diabetes mellitus type 2.Conclusions The patients of DMPC had distint characteristics compared with those of diabetes mellitus type 2.It is possible to improve the diagnosis of the early pancreatic carcinoma by these characteristics.
出处 《北京医学》 CAS 北大核心 2002年第5期298-300,共3页 Beijing Medical Journal
关键词 胰腺癌 早期诊断 糖尿病 合并症 临床特点 Pancreatic carcinoma Early diagnosis Diabetes mellitus
  • 相关文献

参考文献2

二级参考文献24

  • 1[1]Ariyama J,Suyama M,Satoh K,et al.Imaging of small pancreatic ductal adenocarcinoma.Pancreas, 1998,16(3):396-401
  • 2[2]Cerwenka H,Aigner R,Quehenbeger F,et al.Preoperative differential diagnosis of benign and malignant pancreatic lesions-the value of pancreatic secretory trypsin inhibitor,procarboxypeptidase B,CA19-9 and CEA. Hepatogastroenterology, 1997,44(66):1117-21
  • 3[3]Safi F,Schlosser W, Falkenreck S, et al. Prognostic value of CA19-9 serum course in pancreatic cancer. Hepatogastroenterology, 1998,45(19):253-9
  • 4[4]Montgomery RC, Hoffman JP, Riley LB, et al.Preolition of recurrence and survival by postresection CA19-9 values in patients with adenocarcionma of the pancreas.Ann Surg Oncol, 1997,4(7):551-6
  • 5[5]Gogas H, Lofts FJ, Evans TR,et al.Are serial measurements of CA19-9 useful in predicting response to chemotherapy in patients with inoperable adenocarainoma of the pancreas?Br J Cancer, 1998,77(2):325-8
  • 6[6]Yiannakou JY,Newland P,Calder F, et al.Prospective study of CAM17.1/WGA mucin assay for serological diagnosis of pancreatic cancer. Lancet, 1997,349:389(9049)-92
  • 7[7]Reubi JC, Waser B, Friess H,et al. Neurotensin receptors:a new marker for human ductal pancreatic adenocarcinoma. Gut, 1998,42(4):546-50
  • 8[8]Ichikawa T, Haradome H,Hachiya J,et al.pancreatic ductal adenocarcinoma:preoperative assessment with helical CT versus dynamic MR imaging. Radiology, 1997,202(3):655-62
  • 9[9]Irie H,Honda H,Kaneko K,et al.Comparison of helical CT and MR imaging in detecting and staging small pancreatic adenocarcinoma. Abdom Imaging, 1997,22(4):429-33
  • 10[10]Reptopoulos V,Steer ML,Sheiman RG,et al.The use of helical CT and CT angiography to predict vascular involvement from pancreatic cancer:correlation with findings at surgery.AJR Am J Roentgenol, 1997,168(4):971-7

共引文献33

同被引文献43

  • 1王东海,王农荣,林继敏.胰腺癌合并糖代谢异常临床分析[J].中原医刊,2005,32(17):49-50. 被引量:1
  • 2季尚玮,郭宏华,王江滨.糖尿病与消化系肿瘤关系的研究进展[J].国际消化病杂志,2006,26(1):61-63. 被引量:25
  • 3杨红 钱家鸣 郭涛 张惠广 邓兆斌.胰腺癌的临床特点及治疗[J].胰腺病学,2003,3:138-138.
  • 4赵玉沛.胰腺癌外科治疗的难点和突破点[J].胰腺病学,2003,3:51-51.
  • 5Meisterfeld R, Ehehalt F, Saeger HD,et al. Pancreatic disorders and diabetes mellitus[J]. Exp Clin Endocrinol Diabetes, 2008,116 (Suppl 1):S7-S12.
  • 6Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, et al. Type-Ⅱ diabetes and pancreatic eancer:a meta-analysis of 36 studies [J]. Br J Cancer, 2005,92 (11) : 2076-2083.
  • 7Fisher WE. Diabetes:risk factor for the development of pancreatic cancer ormanifestation of the disease[J]? World J Surg, 2001,25 (4) :503-508.
  • 8Capstur SM, Cann PH, Lowe W, et al. Abnormal glucose metabolism and pancreatic cancer mortality[J]. JAMA, 2000, 283(19) :2552-2557.
  • 9Adomi HO,Mclaughlin J,Ekbom A,et al. Cancer risk in patients with diabetes mellitus [J]. Cancer Causes Control, 1994,2: 307- 314.
  • 10Bosseckert H. How much diagnostics in patients with pancreatic cancer [J]? Zentralbl Chir, 2003,128 (5) : 368-374.

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部